Red Blood Cell Contribution to Thrombosis in Polycythemia Vera and Essential Thrombocythemia
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031417 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Julien M P Grenier und 2 weiteren Autor:innen. Beteiligte Einrichtung: Etablissement Français du Sang PACA-Corse, Aix Marseille University, CNRS, ADES UMR 7268, 13005 Marseille, France. Hauptthemen laut MEDLINE: Polycythemia Vera, Thrombocythemia, Essential, Thrombosis, Thrombocytosis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Laboratory of Excellence GR-Ex, Etablissement Français du Sang (EFS), Aix-Marseille University (AMU), Centre National de la Recherche Scientifique (CNRS).
Abstract (Originalsprache)
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms (MPN) characterized by clonal erythrocytosis and thrombocytosis, respectively. The main goal of therapy in PV and ET is to prevent thrombohemorrhagic complications. Despite a debated notion that red blood cells (RBCs) play a passive and minor role in thrombosis, there has been increasing evidence over the past decades that RBCs may play a biological and clinical role in PV and ET pathophysiology. This review summarizes the main mechanisms that suggest the involvement of PV and ET RBCs in thrombosis, including quantitative and qualitative RBC abnormalities reported in these pathologies. Among these abnormalities, we discuss increased RBC counts and hematocrit, that modulate blood rheology by increasing viscosity, as well as qualitative changes, such as deformability, aggregation, expression of adhesion proteins and phosphatidylserine and release of extracellular microvesicles. While the direct relationship between a high red cell count and thrombosis is well-known, the intrinsic defects of RBCs from PV and ET patients are new contributors that need to be investigated in depth in order to elucidate their role and pave the way for new therapeutical strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Etablissement Français du Sang PACA-Corse, Aix Marseille University, CNRS, ADES UMR 7268, 13005 Marseille, France.
- Laboratoire d'Excellence GR-Ex, 75015 Paris, France.
ORCID-Profile: Wassim El Nemer
Förderung
- Agence Nationale de la Recherche
- Laboratory of Excellence GR-Ex
- Etablissement Français du Sang (EFS), Aix-Marseille University (AMU), Centre National de la Recherche Scientifique (CNRS)
- French National Research Agency
- IdEx program “Investissements d’avenir” of the French National Research Agency
Zitieren
APA
Grenier, J. M. P., El Nemer, W., & De Grandis, M. (2024). Red Blood Cell Contribution to Thrombosis in Polycythemia Vera and Essential Thrombocythemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031417
Vancouver
Grenier JMP, El Nemer W, De Grandis M. Red Blood Cell Contribution to Thrombosis in Polycythemia Vera and Essential Thrombocythemia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031417
BibTeX
@article{Grenier2024,
author = {Grenier, Julien M P and El Nemer, Wassim and De Grandis, Maria},
title = {Red Blood Cell Contribution to Thrombosis in Polycythemia Vera and Essential Thrombocythemia},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031417}
}
EUVIMED